- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Advances in Preventive Medicine
Volume 2012 (2012), Article ID 149737, 4 pages
The Need for Continued Development of Ricin Countermeasures
1Division of Clinical Medicine, Clinical Research Management Inc., Team Ke’aki Tech, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA
2Division of Toxinology, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA
Received 1 August 2011; Accepted 10 January 2012
Academic Editor: Phillip R. Pittman
Copyright © 2012 Ronald B. Reisler and Leonard A. Smith. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- G. A. Balint, “Ricin: the toxic protein of castor oil seeds,” Toxicology, vol. 2, no. 1, pp. 77–102, 1974.
- Centers for Disease Control and Prevention, “Biological and chemical terrorism: strategic plan for preparedness and response,” Morbidity and Mortality Weekly Report, vol. 49, no. RR-4, pp. 1–14, 2000.
- J. Cookson and J. Nottingham, A Survey of Chemical and Biological Warfare, vol. 6, Monthly Review Press, New York, NY, USA, 1969.
- M. A. Poli, C. Roy, K. D. Huebner, D. R. Franz, and N. K. Jaax, “Ricin,” in Medical Aspects of Biological Warfare, Z. F. Dembek, Ed., pp. 323–335, Borden Institute, Washington, DC, USA, 2007.
- J. Audi, M. Belson, M. Patel, J. Schier, and J. Osterloh, “Ricin poisoning a comprehensive review,” Journal of the American Medical Association, vol. 294, no. 18, pp. 2342–2351, 2005.
- K. S. Eiklid, S. Olsnes, and A. Pihl, “Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells,” Experimental Cell Research, vol. 126, no. 2, pp. 321–326, 1980.
- A. M. Soler-Rodriguez, J. W. Uhr, J. Richardson, and E. S. Vitetta, “The toxicity of chemically deglycosylated ricin A-chain in mice,” International Journal of Immunopharmacology, vol. 14, no. 2, pp. 281–291, 1992.
- V. Radosavljevic and G. Belojevic, “A new model of bioterrorism risk assessment,” Biosecurity and Bioterrorism, vol. 7, no. 4, pp. 443–451, 2009.
- L. J. Schep, W. A. Temple, G. A. Butt, and M. D. Beasley, “Ricin as a weapon of mass terror—separating fact from fiction,” Environment International, vol. 35, no. 8, pp. 1267–1271, 2009.
- W. T. Porter, An Introduction to Physiology, The University Press, Cambridge, Mass, USA, 1906.
- A. C. Cope, Ricin in Summary Technical Report of Division 9 on Chemical Warfare and Related Problems, chapter 12, Office of Scientific Research and Development, Washington, DC, USA, 1946, Parts I–II. National Defense Research Committee.
- M. A. Poli, V. R. Rivera, M. L. M. Pitt, and P. Vogel, “Aerosolized specific antibody protects mice from lung injury associated with aerosolized ricin exposure,” Toxicon, vol. 33, p. 289, 1996.
- M. A. Poli, V. R. Rivera, M. L. M. Pitt, and P. Vogel, “Aerosolized specific antibody protects mice from lung injury associated with aerosolized ricin exposure,” Toxicon, vol. 34, no. 9, pp. 1037–1044, 1996.
- P. V. Lemley, P. Amanatides, D. Creasia, J. Ruvo, A. O’Neill, and D. C. Stafford, “Chicken antitoxin neutralizes ricin in vitro and in vivo,” Toxicon, vol. 31, p. 527, 1993.
- P. V. Lemley and D. C. Wright, “Active immunization after passive monoclonal antibody and ricin toxin challenge,” Toxicon, vol. 30, p. 531, 1992.
- P. V. Lemley, P. Amanatides, and D. C. Wright, “Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo,” Hybridoma, vol. 13, no. 5, pp. 417–421, 1994.
- P. V. Lemley and D. C. Wright, “Mice are actively immunized after passive monoclonal antibody prophylaxis and ricin toxin challenge,” Immunology, vol. 76, no. 3, pp. 511–513, 1992.
- A. Assaad, J. Hewetson, O. Parker, et al., “A ricin toxoid attenuates acute pulmonary toxicity and improves survival in rats exposed to a lethal dose of ricin aerosol,” Toxicon, vol. 33, p. 277, 1995.
- J. F. Hewetson, V. R. Rivera, P. V. Lemley, M. L. Pitt, D. A. Creasia, and W. L. Thompson, “A formalinized toxoid for protection of mice from inhaled ricin,” Vaccine Research, vol. 4, no. 4, pp. 179–187, 1995.
- R. B. Reisler, “Development and pre-clinical evaluation of a recombitant ricin vaccine (RVEc),” in Proceedings of the 9th ASM Biodefense and Emerging Diseases Research Meeting, Poster 210 (H), Washington, DC, USA, February 2011.
- J. F. Hewetson, et al., “Immune response and protection of rats and mice from ricin aerosol exposure after vaccination with deglycosylated ricin A chain,” Fundamental and Applied Toxicology, vol. 30, supplement, article 59, 1996.
- P. V. Lemley, D. A. Creasia, M. Plesha, D. Walters, and D. O’Neill, “Ricin sub-unit vaccination in mice and protection from challenge,” Toxicon, vol. 32, pp. 545–546, 1994.
- J. E. Smallshaw, A. Firan, J. R. Fulmer, S. L. Ruback, V. Ghetie, and E. S. Vitetta, “A novel recombinant vaccine which protects mice against ricin intoxication,” Vaccine, vol. 20, no. 27-28, pp. 3422–3427, 2002.
- J. E. Smallshaw, J. A. Richardson, S. Pincus, J. Schindler, and E. S. Vitetta, “Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin,” Vaccine, vol. 23, no. 39, pp. 4775–4784, 2005.
- E. S. Vitetta, J. E. Smallshaw, E. Coleman et al., “A pilot clinical trial of a recombinant ricin vaccine in normal humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2268–2273, 2006.
- J. E. Smallshaw and E. S. Vitetta, “A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity,” Vaccine, vol. 28, no. 12, pp. 2428–2435, 2010.
- P. S. Marconescu, J. E. Smallshaw, L. M. Pop, S. L. Ruback, and E. S. Vitetta, “Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication,” Vaccine, vol. 28, no. 32, pp. 5315–5322, 2010.
- Phase 1B Study of RiVax. ClinicalTrials.gov, 2011http://www.clinicaltrials.gov/ct2/show/NCT00812071?term=rivax&rank=1.
- Soligenix Annual Report 2010, 2011, http://www.sec.gov/Archives/edgar/data/812796/000121390011001567/f10k2010_soligenix.htm.
- M. A. Olson, J. H. Carra, V. Roxas-Duncan, R. W. Wannemacher, L. A. Smith, and C. B. Millard, “Finding a new vaccine in the ricin protein fold,” Protein Engineering, Design and Selection, vol. 17, no. 4, pp. 391–397, 2004.
- J. H. Carra, R. W. Wannemacher, R. F. Tammariello et al., “Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity,” Vaccine, vol. 25, no. 21, pp. 4149–4158, 2007.
- M. M. Meagher, J. G. Seravalli, S. T. Swanson, et al., “Process development and cGMP manufacturing of a recombinant ricin vaccine: an effective and stable recombinant ricin a-chain vaccine-RVEc,” Biotechnology Progress, vol. 27, no. 4, p. 1036, 2011.
- D. E. McLain, T. L. Horn, C. J. Detrisac, C. Y. Lindsey, and L. A. Smith, “Progress in biological threat agent vaccine development: a repeat-dose toxicity study of a recombinant ricin toxin A-chain (rRTA) 1-33/44-198 vaccine (RVEc) in male and female New Zealand white rabbits,” International Journal of Toxicology, vol. 30, no. 2, pp. 143–152, 2011.
- A. Porter, G. Phillips, L. Smith, et al., “Evaluation of a ricin vaccine candidate (RVEc) for human toxicity using an in vitro vascular leak assay,” Toxicon, vol. 58, no. 1, pp. 68–75, 2011.
- RVEc Phase I Human Clinical Trial, 2011, http://www.usamriid.army.mil/newsroom.cfm.
- Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc), 2011, http://www.clinicaltrials.gov/ct2/show/NCT01317667?term=rvec&rank=1.
- L. M. Neal, J. O'Hara, R. N. Brey, and N. J. Mantis, “A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin,” Infection and Immunity, vol. 78, no. 1, pp. 552–561, 2010.
- L. M. Neal, E. A. McCarthy, C. R. Morris, and N. J. Mantis, “Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA,” Vaccine, vol. 29, no. 4, pp. 681–689, 2011.
- J. Prigent, L. Panigai, P. Lamourette et al., “Neutralising antibodies against Ricin Toxin,” Plos ONE, vol. 6, no. 5, Article ID e20166, 2011.
- B. Stechmann, S. K. Bai, E. Gobbo et al., “Inhibition of retrograde transport protects mice from lethal ricin challenge,” Cell, vol. 141, no. 2, pp. 231–242, 2010.
- P. G. Wahome, J. D. Robertus, and N. J. Mantis, “Small-molecule inhibitors of ricin and shiga toxins,” Current Topics in Microbiology and Immunology, vol. 357, pp. 179–207, 2012.
- V. St. Georgiev, “National institute of allergy and infectious diseases,” in Impact on Global Health, vol. 2, pp. 274–277, Humana Press, New York, NY, USA, 2009.